Expression of CD73 is induced by hypoxia and by inflammatory mediators such as TGF-β [3] so that in the tumor microenvironment, its expression is not confined to cancer cells but is also detectable on tumor-infiltrating immune effectors, such as macrophages, dendritic cells, and lymphocytes [3,5]. The gene discussed is NT5E; the disease is cancer.